Meeder Asset Management Inc Age X Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.53 - $1.09 $64 - $131	-121 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$1.56 - $2.7 $188 - $326	121 New	121 $0
Q4 2020 Feb 09, 2021	SELL	$0.8 - $2.56 $96 - $309	-121 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.78 - $1.95 $755 - $1,889	-969 Reduced 88.9%	121 $0
Q4 2019 Feb 13, 2020	BUY	$1.25 - $1.82 $591 - $860	473 Added 76.66%	1,090 $2,000
Q3 2019 Oct 17, 2019	BUY	$1.96 - $3.38 $317 - $547	162 Added 35.6%	617 $1,000
Q2 2019 Aug 05, 2019	BUY	$2.58 - $4.92 $23 - $44	9 Added 2.02%	455 $2,000
Q1 2019 Apr 16, 2019	SELL	$3.0 - $4.85 $333 - $538	-111 Reduced 19.93%	446 $2,000
Q4 2018 Jan 17, 2019	BUY	$2.49 - $5.5 $1,386 - $3,063	557 New	557 $1,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.